tiprankstipranks
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (DE:RMEA)
FRANKFURT:RMEA

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMEA) Price & Analysis

1 Followers

RMEA Stock Chart & Stats

€16.20
-€0.10(-0.61%)
At close: 4:00 PM EDT
€16.20
-€0.10(-0.61%)

Bulls Say, Bears Say

Bulls Say
Financial PerformanceThe company reported strong devices growth, contributing to a solid Q2 performance with earnings exceeding expectations.
Valuation And GrowthUpgrade to Buy on reasonable valuation, strong EPS growth, FCF, and no debt by FY end.
Bears Say
Growth ConstraintsHealthcare systems’ capacity constraints will likely keep a lid on new patients growth.
Market SentimentRMD’s share price has historically reacted negatively to news flow on GLP-1s.

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh News

RMEA FAQ

What was Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price range in the past 12 months?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh lowest stock price was €15.30 and its highest was €24.60 in the past 12 months.
    What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s market cap?
    Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s market cap is €26.53B.
      When is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s upcoming earnings report date?
      Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s upcoming earnings report date is Aug 06, 2026 which is in 4 days.
        How were Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s earnings last quarter?
        Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh released its earnings results on Apr 30, 2026. The company reported €0.248 earnings per share for the quarter, beating the consensus estimate of €0.243 by €0.005.
          Is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh overvalued?
          According to Wall Street analysts Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pay dividends?
            Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh does not currently pay dividends.
            What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s EPS estimate?
            Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s EPS estimate is 0.25.
              How many shares outstanding does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh have?
              Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has 1,450,563,800 shares outstanding.
                What happened to Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price movement after its last earnings report?
                Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh reported an EPS of €0.248 in its last earnings report, beating expectations of €0.243. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh?
                  Currently, no hedge funds are holding shares in DE:RMEA
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh Stock Smart Score

                    Company Description

                    Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

                    ResMed Inc. designs, manufactures, and markets innovative medical devices and sophisticated cloud-based software platforms for the global healthcare industry, operating through its Sleep and Respiratory Care, and Software as a Service divisions. Within its Sleep and Respiratory Care segment, the company offers a comprehensive range of solutions for various respiratory disorders. These include cutting-edge ventilation devices, diagnostic tools, diverse mask systems suitable for hospital and home environments, headgear, accessories, and specialized dental devices. These hardware offerings are integrated with cloud-based informatics solutions designed to optimize patient management and improve clinical results. Prominent software applications in this area feature AirView, a cloud platform for remote patient monitoring and device setting modifications; myAir, a personalized therapy management tool for sleep apnea sufferers, providing education, support, and troubleshooting to enhance engagement and adherence; and U-Sleep, a compliance monitoring system that streamlines sleep programs for home medical equipment (HME) providers. The company also offers connectivity modules and Propeller solutions. The Software as a Service division specializes in out-of-hospital care solutions. Brightree provides business management software and services to providers in the home medical equipment, pharmacy, home infusion, orthotics, and prosthetics sectors. MatrixCare delivers care management and ancillary solutions to senior living communities, skilled nursing facilities, life plan communities, home health, home care, and hospice organizations, including related accountable care organizations. Furthermore, HEALTHCAREfirst supplies electronic health record (EHR) systems, software, billing and coding services, and analytics tailored for home health and hospice agencies. ResMed distributes its extensive product line to sleep clinics, home healthcare dealers, and hospitals in approximately 140 countries, utilizing both a direct sales force and a network of distributors. The company was founded in 1989 and is based in San Diego, California.

                    Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMEA) Earnings & Revenues

                    RMEA Revenue Breakdown

                    88.21%88.21%11.79%
                    88.21% Sleep and Respiratory Care
                    11.79% Software as a Service
                    tipranks

                    RMEA Stock 12 Month Forecast

                    Average Price Target

                    €23.74
                    ▲(46.53% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"14":"€14","29":"€29","17.75":"€17.75","21.5":"€21.5","25.25":"€25.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":28.242815399999998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€28.24</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23.73799110428571,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€23.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20.606346,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€20.61</span>\n  </div></div>","useHTML":true}}],"tickPositions":[14,17.75,21.5,25.25,29],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.6,18.41867810769231,19.237356215384615,20.056034323076922,20.874712430769232,21.69339053846154,22.512068646153846,23.330746753846153,24.14942486153846,24.96810296923077,25.786781076923077,26.605459184615384,27.42413729230769,{"y":28.242815399999998,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.6,18.072153161868133,18.544306323736265,19.016459485604397,19.48861264747253,19.96076580934066,20.432918971208792,20.90507213307692,21.377225294945053,21.849378456813184,22.321531618681316,22.793684780549448,23.26583794241758,{"y":23.73799110428571,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.6,17.831257384615387,18.06251476923077,18.293772153846156,18.52502953846154,18.756286923076924,18.987544307692307,19.218801692307693,19.450059076923075,19.68131646153846,19.912573846153844,20.14383123076923,20.375088615384612,{"y":20.606346,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":23.562,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.819,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.819,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.827,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.687,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.687,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.886,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.933,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.939,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.544,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.9,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.7,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.6,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Compumedics Limited
                    Somnomed Limited
                    Paragon Care Limited
                    Alcidion Group Limited
                    4DMedical Ltd
                    Popular Stocks